髋关节MRI表现与影像引导下髋关节注射后疗效的关系
这项前瞻性疗效研究回顾性评估了100例连续患者在治疗性髋关节腔内注射前6个月内的MRI,由两名对疗效不知情的放射科医生评估盂唇、骨髓、髋臼及股骨软骨异常;比较不同MRI表现患者的PGIC改善比例及疼痛变化评分。结论:软骨缺损和骨髓异常与疗效无关;后上象限盂唇正常者1周时疗效更好;前下象限盂唇退变者各时间点疼痛减轻更明显;女性报告PGIC改善的可能性显著更高。
要点
- 后上象限盂唇正常者1周时PGIC改善比例高于盂唇退变者(p=0.048)。
- 前下象限盂唇退变者各时间点疼痛减轻最明显(1天p=0.001,1周p=0.010,1个月p=0.034)。
- 软骨缺损和骨髓异常与注射后疗效无关。
核心结论
- 软骨缺损和骨髓异常与髋关节腔内注射后的疗效无关。
- 后上象限盂唇正常者1周时疗效更好;前下象限盂唇退变者各时间点疼痛减轻更明显;女性报告PGIC改善的可能性显著更高。
研究设计与样本
- 前瞻性疗效研究,回顾性评估MRI,纳入100例连续患者,均在治疗性髋关节腔内注射前6个月内完成MRI。
- 由两名对患者疗效不知情的放射科医生评估盂唇、骨髓、髋臼软骨及股骨软骨异常。
- 采用χ2检验比较不同MRI表现患者在第1天、1周和1个月随访时PGIC量表报告「改善」的比例;采用t检验比较疼痛变化评分与MRI异常的关系。
关键影像表现/征象
- 后上象限盂唇正常者1周时报告PGIC「改善」的比例高于盂唇退变者(p=0.048)。
- 前下象限盂唇退变者各时间点疼痛减轻最明显(1天p=0.001,1周p=0.010,1个月p=0.034)。
- 软骨缺损和骨髓异常与疗效无关。
诊断标准与关键数值
- 以PGIC量表报告「改善」作为疗效指标,分别于注射后第1天、1周和1个月评估。
- 女性第1天报告临床相关「改善」的可能性是男性的2.80倍(p=.049),第1个月是2.90倍(p=.045)。
临床应用与阅片要点
- 阅片时可关注后上象限盂唇是否正常及前下象限盂唇有无退变,这两处表现与注射后疗效相关。
- 软骨缺损和骨髓异常似乎不影响注射疗效判断。
- 女性患者报告PGIC改善的可能性更高,解读疗效时需结合性别因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To determine if MRI findings prior to intra-articular corticosteroid hip infiltration are related to treatment outcomes.
METHODS: This prospective outcome study with retrospective MRI evaluation includes 100 consecutive patients with MRI within 6 months before a therapeutic intra-articular hip injection. Labrum, bone marrow, acetabular and femoral cartilage abnormalities were assessed by two radiologists blinded to patient outcomes: the proportion reporting "improvement" on the Patient's Global Impression of Change (PGIC) scale at 1 day, 1 week and 1 month follow-up were compared based on MRI findings using χ2. The t-test was used to compare pain change scores with MRI abnormalities.
RESULTS: Patients with a normal labrum in the posterosuperior quadrant were more likely to report PGIC "improvement" at 1 week compared to labral degeneration (p = 0.048). Significant differences in pain change scores were found at all time points for the labral anteroinferior quadrant (p = 0.001, 1 day; p = 0.010, 1 week; p = 0.034, 1 month) with the highest reduction in patients with labral degeneration. Females were 2.80 times more likely to report clinically relevant "improvement" at 1 day (p = .049) and 2.90 times more likely to report clinically relevant "improvement" at 1 month (p = .045).
CONCLUSION: Cartilage defects and marrow abnormalities were not associated with outcomes. Patients with a normal labrum in the posterosuperior quadrant had better outcomes at 1 week. Patients with labral degeneration of the anteroinferior quadrant had higher levels of pain reduction at all time points. Females were significantly more likely to report PGIC "improvement".
ADVANCES IN KNOWLEDGE: A significant treatment outcome was observed amongst gender, although there were no significant differences in the MRI findings.
引用
- Pochon L, Peterson CK, Sutter R, et al. Hip MRI findings and outcomes following imaging-guided hip injections. Br J Radiol. 2020. PMID: 31899657. doi:10.1259/bjr.20190817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。